Mechanisms of chemotherapeutic-induced hearing loss and otoprotection

Adrien A. Eshraghi, Michael Bublik, Thomas R. Van De Water

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Cisplatin (CDDP) and carboplatin are highly effective chemotherapeutic agents with ototoxic side effects that limit their efficacy. Formation of reactive oxygen species (ROS) in CDDP-exposed cochlear tissues is involved in ototoxic action of the CDDP on hair cells. Downstream targets of ROS are cell death mediator molecules, for example, p53 and activated caspases. The efficacy of several otoprotective compounds is discussed in relationship to their impact on protection of hearing and potential for interfering with the chemotherapeutic treatment of cancer.

Original languageEnglish (US)
Pages (from-to)125-130
Number of pages6
JournalDrug Discovery Today: Disease Mechanisms
Volume3
Issue number1
DOIs
StatePublished - Jul 19 2006

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Mechanisms of chemotherapeutic-induced hearing loss and otoprotection'. Together they form a unique fingerprint.

Cite this